Tin tức & Cập nhật
Xem bài viết Tim mạch
Xem
Chỉ hiển thị Multimedia

Lorundrostat for uncontrolled hypertension hits efficacy, safety targets in phase III trial
10 Jul 2025
bởiJairia Dela Cruz
Twelve weeks of treatment with the aldosterone synthase inhibitor lorundrostat proved efficacious and safe for lowering blood pressure (BP) in adults with uncontrolled hypertension, including those who were resistant to treatment, according to the phase III Launch-HTN trial.








